Should You Invest In Prana Biotechnology Limited (PRAN), IsoRay, Inc.(ISR) and VIVUS, Inc.(VVUS)?

Posted by admin February 17, 2015 0 Comment 2288 views

New York, NY – GDP INSIDER  –  02/17/2015.

This article discusses three companies: Prana Biotechnology Limited (ADR)(NASDAQ:PRAN), IsoRay, Inc.(NYSEMKT:ISR) and VIVUS, Inc.(NASDAQ:VVUS)

Prana Biotechnology Limited (ADR)(NASDAQ:PRAN) lost $1.09 to finish the day at a closing price of $1.09. The 33.54% decline in value came on a day when the stock traded for as little as $1.07, a new 52 week low for Melbourne-based biotechnology company which once traded for as high as $12.22 in February last year. The company’s volume spiked to a figure of 5.47 million Friday, which is significantly higher than its three months average trading volume of 281.10K. Prana Biotechnology Limited has an RSI of 25.69, indicating the stock’s value might have fallen too quickly. The stock, however, rose 0.92% during afterhours trading.

Is It Now The Time To Sell Shares Of Prana Biotechnology Limited? Read Our Free PRAN Analysis And Get A Jump On Wall Street.

IsoRay, Inc.(NYSEMKT:ISR) suffered a decline of 4.29% in value as the stock lost six cents to move to a new closing price of $1.34. The $73.54 million market cap company, which oscillated between $1.33 and $1.43 during Friday’s trading, has an earnings per share of $-0.12 and a beta of -0.97, which shows its inverse relation with the market. IsoRay, Inc has traded between $0.67 and $3.77 over the last one year and has a one year target price estimate of $5 offering plenty of upside potential but with significant short term risk.

Will IsoRay, Inc’s Value Continue To Fall? For Complete Insight Into ISR Click Here For A Free Analysis.

VIVUS, Inc.(NASDAQ:VVUS) popped 5.10% during Friday’s trading as the stock gained thirteen cents to move to a closing price of $2.68. The stock gained an additional three cents during afterhours trading to move to a value of $2.71. Despite the gain, the stock still remains 62.93% below its one year high of $7.23. The stock has been trading in the range of $2-3 in recent months, which is below its 1 year price target estimate of $3.30. VIVUS, Inc has an insider ownership of 0.30% and a 6-month change in insider ownership of 481.62%. With strong earnings growth of 68.80%, gross margin (ttm) of 80.20% and a current ratio of 6.60, the stock holds a good long term investment potential.

Will VIVUS, Inc Continue Gaining Upside Momentum? Receive Our Free VVUS Analysis Here.

About UltimateStockAlerts provides investors and traders with trading strategies via text message and email. To obtain text message stock alerts service text the word ULTIMATE to 555888 from your cell phone.

UltimateStockAlerts continuously monitors and scans the markets for day trading and swing trading signals on NASDAQ, NYSE, AMEX, OTCBB and Pink Sheet companies for its free e-newsletter subscribers.

Disclosure:  UltimateStockAlerts is not a registered investment adviser and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit website, for complete risks and disclosures.

Write Your Comment